Clean Earth (CLIN) Lowers Alternus Valuation in Deal Tweak
by Marlena Haddad on 2023-04-18 at 5:57pm

Clean Earth Acquisitions Corp. (NASDAQ:CLIN) announced in an 8-K this afternoon that it has lowered the valuation for its climate technology target Alternus (OSE:ALT) and reduced the earnout shares for the deal.

At deal announcement, Alternus had a pre-money valuation of $550 million and Clean Earth originally agreed to issue Alternus Energy a number of shares equal to $550 million plus or minus an estimated working capital adjustment, of which 1,000,000 shares would be deposited into a working capital escrow account to satisfy any post-closing working capital adjustments.

But, the parties have now agreed to reduce this valuation by 50%, from $550 million to $275 million.

As a result of this change, Clean Earth will issue a number of shares to Alternus equal to $275 million, plus or minus an estimated working capital adjustment of which 1,000,000 shares will be deposited into a working capital escrow account.

Additionally, the parties have agreed to reduce the earnout shares from 35 million shares to 20 million shares and modify the earnout milestones.

These shares will be deposited into an earnout escrow account and will be released to Alternus if the Adjusted EBITDA for the fiscal year ending on December 31, 2023 is at least $16 million and the company’s share price is at least $11.00 for a minimum number of trading days, then 6,000,000 shares will be released. If Adjusted EBITDA for the fiscal year ending on December 31, 2024 is at least $52 million and the company’s share price is at least $13.00 for a minimum number of trading days, then 6,000,000 shares will be released. And if Adjusted EBITDA for the fiscal year ending on December 31, 2025 is at least $156 million and the company’s share price is at least $15.00 for a minimum number of trading days, then 8,000,000 earnout shares will be released to Alternus.

If any of the earnout milestones are not met, the earnout shares that would have been released to the seller will be released if a subsequent earnout milestone is met. In addition, if any earnout milestone based on Adjusted EBITDA has been met, but the corresponding earnout milestone based on share price has not been met, the shares may be released if share price targets or a calculated share price based on a multiple of Adjusted EBITDA reduced by net debt are met during the five-year period from the date of the applicable milestone.

Furthermore, Citigroup, one of the underwriters of Clean Earth’s IPO, agreed to forfeit the remaining deferred discount payment of $3,622,500 that is to be paid to them upon the consummation of a business combination, such that when taken together with that certain letter agreement, Citigroup agrees to forfeit the entire deferred discount payment of $7,245,000.

Clean Earth announced its $992 million deal with Alternus in October 2022. Dublin, Ireland-based Alternus installs, owns and operates midsized utility scale solar plants and plans to have about 3.5 GW of generation assets in this portfolio by 2025.

Recent Posts
by Nicholas Alan Clayton on 2024-11-26 at 10:42am

FACT II Acquisition Corp. (NASDAQ:FACTU) announced the pricing of its $175 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “FACTU”, Tuesday, November 26, 2024. The new SPAC intends to conduct a broad search and combine with a target company that has demonstrated operating expertise over the past...

by Nicholas Alan Clayton on 2024-11-26 at 8:29am

At the SPAC of Dawn The market is set to get a raft of housing and construction indicators today ranging from building permits to home prices and new home sales. This comes as the picture for the construction market itself is undergoing some major changes. Concrete manufacturer Quikrete yesterday announced plans to buy rival Summit...

by Nicholas Alan Clayton on 2024-11-25 at 2:41pm

Inflection Point Acquisition Corp. III (NASDAQ:COLAU) has filed for a $220 million IPO just as the team’s first deal reaches lift off. The SPAC has made the increasingly popular move to eschew warrants in favor of putting rights to a 1/10 share in its units and will not overfund its trust. These terms, along with...

by Nicholas Alan Clayton on 2024-11-25 at 8:17am

At the SPAC of Dawn Though normally a week of dampened activity dominated by food-induced drowsiness, SPACs have a relatively full plate coming their way over the next three and a half market sessions. Both FACT II (NASDAQ:FACTU) and Tavia (NASDAQ:TAVIU) are angling to price their IPOs, which would follow two last week and six...

by Kristi Marvin on 2024-11-23 at 10:01am

Terms Tracker for the Week Ending November 22, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. SPACs finally broke the DeSPAC announcement drought exactly 30 days from the last DeSPAC announcement with Hudson Acquisition I Corp.’s news they had reached the...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved